Advertisement
Advertisement
U.S. markets open in 1 hour 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4900+0.0100 (+2.08%)
At close: 04:00PM EDT
0.4700 -0.02 (-4.08%)
After hours: 04:33PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.4800
Open0.4760
Bid0.0000 x 2900
Ask0.0000 x 2900
Day's Range0.4700 - 0.4909
52 Week Range0.4500 - 2.3800
Volume4,310
Avg. Volume33,196
Market Cap42.784M
Beta (5Y Monthly)1.10
PE Ratio (TTM)N/A
EPS (TTM)-0.0890
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for XTNT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Xtant Medical Holdings, Inc.
    Analyst Report: Integra Lifesciences Hldgs CorBased in Plainsboro, New Jersey, Integra is an integrated medical device company that develops and markets devices for use in neurosurgery and wound repair. The company's products are used in cranial and spinal procedures, peripheral nerve repair, the repair of skin and deeper tissue from burns and vehicular accidents, and the repair and reconstruction of soft tissue. It operates in two segments: Codman Specialty Surgical, and Tissue Technologies. The company also markets products through private-label relationships with other medical device companies.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • GlobeNewswire

    Xtant Medical Announces First Quarter 2022 Financial Results

    BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022. “By building momentum in our business, underscored by first quarter revenue growth and the progress of our key strategic growth pillars, we are pleased with the promising start to 2022,” said Sean Brown

  • GlobeNewswire

    Xtant Medical Appoints Scott Neils as Chief Financial Officer

    BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective June 1, 2022. “Scott’s success and experience during his tenure at Xtant, including his recent position as interim Chief Financial Officer, makes him an invaluable member of our team,” said Sean Browne, Presi

  • GlobeNewswire

    Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

    BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2022, before the open of the financial markets on Thursday, May 5, 2022. Sean Browne, President and Chief Executive Officer, and Scott Neils, Interim Chief Financial Officer, will host a confere

Advertisement
Advertisement